Encapsulation of Inositol Hexakisphosphate with Chitosan via Gelation to Facilitate Cellular Delivery and Programmed Cell Death in Human Breast Cancer Cells
Inositol hexakisphosphate (InsP ) is the most abundant inositol polyphosphate both in plant and animal cells. Exogenous InsP is known to inhibit cell proliferation and induce apoptosis in cancerous cells. However, cellular entry of exogenous InsP is hindered due to the presence of highly negative ch...
Saved in:
Published in: | Bioengineering (Basel) Vol. 11; no. 9; p. 931 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
MDPI AG
17-09-2024
MDPI |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Inositol hexakisphosphate (InsP
) is the most abundant inositol polyphosphate both in plant and animal cells. Exogenous InsP
is known to inhibit cell proliferation and induce apoptosis in cancerous cells. However, cellular entry of exogenous InsP
is hindered due to the presence of highly negative charge on this molecule. Therefore, to enhance the cellular delivery of InsP
in cancerous cells, InsP
was encapsulated by chitosan (CS), a natural polysaccharide, via the ionic gelation method. Our hypothesis is that encapsulated InsP
will enter the cell more efficiently to trigger its apoptotic effects. The incorporation of InsP
into CS was optimized by varying the ratios of the two and confirmed by InsP
analysis via polyacrylamide gel electrophoresis (PAGE) and atomic absorption spectrophotometry (AAS). The complex was further characterized by Scanning Electron Microscopy (SEM) and Fourier Transform Infrared Spectroscopy (FTIR) for physicochemical changes. The data indicated morphological changes and changes in the spectral properties of the complex upon encapsulation. The encapsulated InsP
enters human breast cancer MCF-7 cells more efficiently than free InsP
and triggers apoptosis via a mechanism involving the production of reactive oxygen species (ROS). This work has potential for developing cancer therapeutic applications utilizing natural compounds that are likely to overcome the severe toxic effects associated with synthetic chemotherapeutic drugs. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2306-5354 2306-5354 |
DOI: | 10.3390/bioengineering11090931 |